임상 한눈에 보기

• 6건의 ClinicalTrials.gov 임상 기록
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• 모집 중 5건 · 완료/종료 0건
• Phase: Phase 2, Phase 3 · Phase 1, Phase 2
• Status: Recruiting · Active, not recruiting · Withdrawn
• 주요 endpoint: Phase 1/2: Incidence and severity of adverse events (AEs) · Phase 2b Sub-study 1: Proportion of DM & ASyS subjects achieving at least a moderate Total Improvement Score (TIS) without any immunomodulatory medications and no or low dose of steroids · Phase 2b Sub-study 2: Proportion of subjects with IMNM achieving at least a minimal TIS without any immunomodulatory medications and no or low dose of steroids · Incidence of adverse events and laboratory abnormalities · Pharmacodynamics (PD)
• 등록 대상자(표본 합산): 약 166명

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다. 효능 수치는 선택한 등록 결과이며 전적응증 값이 아닙니다.